CROSS SECTIONAL AND LONGITUDINAL 3T MAGNETIC RESONANCE SPECTROSCOPY IN A TRACK-HD COHORT OF INDIVIDUALS WITH PREMANIFEST AND EARLY HUNTINGTON'S DISEASE

被引:0
|
作者
Sturrock, A. [1 ]
Laule, C. [2 ]
Decolongon, J. [1 ]
Santos, R. Dar [1 ]
Coleman, A. J. [1 ]
Creighton, S. [1 ]
Bechtel, N. [3 ]
Reilmann, R. [3 ]
Hayden, M. R. [1 ]
Tabrizi, S. J. [4 ]
Mackay, A. L. [2 ]
Leavitt, B. R. [1 ]
机构
[1] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[2] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada
[3] Univ Munster, Dept Neurol, D-48149 Munster, Germany
[4] UCL, UCL Inst Neurol, London, England
来源
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2010年 / 81卷
关键词
D O I
10.1136/jnnp.2010.222653.6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A35 / A35
页数:1
相关论文
共 47 条
  • [11] SIGNIFICANT BIOLOGICAL AND CLINICAL CHANGE DETECTED OVER 1 YEAR IN PREMANIFEST AND EARLY STAGE HUNTINGTON'S DISEASE IN THE TRACK-HD STUDY
    Tabrizi, S. J.
    Duerr, A.
    Roos, R. A. C.
    Leavitt, B. R.
    Jones, R.
    Landwehrmeyer, G. B.
    Johnson, H.
    Hicks, S. L.
    Kennard, C.
    Reilmann, R.
    Craufurd, D.
    Rosas, H. D.
    Frost, C.
    Langbehn, D. R.
    Scahill, R. I.
    Stout, J. C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A33 - A33
  • [12] Progression of Premanifest and Early Huntington's Disease Detectable After 1 Year-Does TRACK-HD Open the Door to Disease-Modifying Trials in HD and Beyond?
    Reilmann, Ralf
    MOVEMENT DISORDERS, 2011, 26 (04) : 605 - 605
  • [13] Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
    Tabrizi, Sarah J.
    Scahill, Rachael I.
    Owen, Gail
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A.
    Borowsky, Beth
    Landwehrmeyer, Bernhard
    Frost, Chris
    Johnson, Hans
    Craufurd, David
    Reilmann, Ralf
    Stout, Julie C.
    Langbehn, Douglas R.
    LANCET NEUROLOGY, 2013, 12 (07): : 637 - 649
  • [14] A Longitudinal Study of Magnetic Resonance Spectroscopy Huntington's Disease Biomarkers
    Sturrock, Aaron
    Laule, Corree
    Wyper, Katy
    Milner, Ruth A.
    Decolongon, Joji
    Santos, Rachelle Dar
    Coleman, Allison J.
    Carter, Kimberley
    Creighton, Susan
    Bechtel, Natalie
    Bohlen, Stefan
    Reilmann, Ralf
    Johnson, Hans J.
    Hayden, Michael R.
    Tabrizi, Sarah J.
    Mackay, Alex L.
    Leavitt, Blair R.
    MOVEMENT DISORDERS, 2015, 30 (03) : 393 - 401
  • [16] LONGITUDINAL EVALUATION OF MAGNETIC RESONANCE SPECTROSCOPY METABOLITES AS BIOMARKERS IN HUNTINGTON'S DISEASE
    Lowe, Alexander J.
    Rodrigues, Filipe B.
    Arridge, Marzena
    De Vita, Enrico
    Johnson, Eileanoir B.
    Scahill, Rachael I.
    Byrne, Lauren M.
    Tortelli, Rosanna
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild., Edward J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A29 - A32
  • [17] 7T magnetic resonance spectroscopy in Huntington's disease
    Dumas, E.
    van den Bogaard, S.
    Jurgens, C.
    Witjes-Ane, N.
    Teeuwisse, W.
    van Buchem, M.
    van der Grond, J.
    Roos, R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 : A21 - A21
  • [18] Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease
    Lowe, Alexander J.
    Rodrigues, Filipe B.
    Arridge, Marzena
    De Vita, Enrico
    Johnson, Eileanoir B.
    Scahill, Rachael, I
    Byrne, Lauren M.
    Tortelli, Rosanna
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    BRAIN COMMUNICATIONS, 2022, 4 (06)
  • [19] Hydrogen magnetic resonance quantitative spectroscopy at 3 T in symptomatic and asymptomatic Huntington's disease patients
    Alcauter-Solorzano, Sarael
    Pasaye-Alcaraz, Erick H.
    Alvarado-Alanis, Patricia
    Fermin-Delgado, Rafael O.
    Elisa Alonso-Vilatela, M.
    Salgado-Lujambio, Perla
    Barrios, Fernando A.
    REVISTA DE NEUROLOGIA, 2010, 51 (04) : 208 - 212
  • [20] Multi-Modal Neuroimaging in Premanifest and Early Huntington's Disease: 18 Month Longitudinal Data from the IMAGE-HD Study
    Dominguez D, Juan F.
    Egan, Gary F.
    Gray, Marcus A.
    Poudel, Govinda R.
    Churchyard, Andrew
    Chua, Phyllis
    Stout, Julie C.
    Georgiou-Karistianis, Nellie
    PLOS ONE, 2013, 8 (09):